Papers - ZHAO Songji
-
All-trans retinoic acid enhances murine dendritic cell migration to draining lymph nodes via the balance of matrix metalloproteinases and their inhibitors.
Darmanin S, Chen J, Zhao S, Cui H, Shirkoohi R, Kubo N, Kuge Y, Tamaki N, Nakagawa K, Hamada J, Moriuchi T, Kobayashi M
Journal of Immunology 179 ( 7 ) 4616 - 4625 2007.10
-
Comparison of MET-PET and FDG-PET for differentiation between benign lesions and lung cancer in pneumoconiosis.
Kanegae K, Nakano I, Kimura K, Kaji H, Kuge Y, Shiga T, Zhao S, Okamoto S, Tamaki N
Annals of Nuclear Medicine 21 ( 6 ) 331 - 337 2007.8
-
Evaluating performance of a pixel array semiconductor SPECT system for small animal imaging.
Kubo N, Zhao S, Fujiki Y, Kinda A, Motomura N, Katoh C, Shiga T, Kawashima H, Kuge Y, Tamaki N
Annals of Nuclear Medicine 19 ( 7 ) 633 - 639 2005.10
-
Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99mTc-Annexin V, 18F-FDG, and histologic evaluation.
Takei T, Kuge Y, Zhao S, Sato M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N
Journal of Nuclear Medicine 46 ( 5 ) 794 - 799 2005
-
Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor.
Zhao S, Kuge Y, Mochizuki T, Takahashi T, Nakada K, Sato M, Takei T, Tamaki N
Journal of Nuclear Medicine 46 ( 4 ) 675 - 682 2005.4
-
Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Nakada K, Ishibashi T, Takei T, Hirata K, Shinohara K, Katoh S, Zhao S, Tamaki N, Noguchi Y, Noguchi S.
J Nucl Med 46 ( 2 ) 261 - 266 2005.2
-
Time course of apoptotic tumor response after a single dose of chemotherapy: comparison with 99mTc-annexin V uptake and histologic findings in an experimental model.
Takei T, Kuge Y, Zhao S, Sato M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N
Journal of Nuclear Medicine 45 ( 12 ) 2083 - 2087 2004.12
-
Gastrointestinal uptake of FDG after N-butylscopolamine or omeprazole treatment in the rat.
Yamamoto F, Nakada K, Zhao S, Satoh M, Asaka M, Tamaki N
Annals of Nuclear Medicine 18 ( 7 ) 637 - 640 2004.10
-
18F-FDG PET is superior to 67Ga SPECT in the staging of non-Hodgkin's lymphoma.
Yamamoto F, Tsukamoto E, Nakada K, Takei T, Zhao S, Asaka M, Tamaki N
Annals of nuclear medicine 18 519 - 526 2004
-
Feasibility of 99mTc-annexin V for repetitive detection of apoptotic tumor response to chemotherapy: an experimental study using a rat tumor model.
Kuge Y, Sato M, Zhao S, Takei T, Nakada K, Seki KI, Strauss HW, Blankenberg FG, Tait JF, Tamaki N
Journal of Nuclear Medicine 45 ( 2 ) 309 - 312 2004.2
-
Effect of steroids on [18F]fluorodeoxyglucose uptake in an experimental tumor model
Zhao S, Kuge Y, Nakada K, Mochizuki T, Takei T, Okada F, Tamaki N.
Nucl Med Commun 25 ( 7 ) 727 - 730 2004.7
-
Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism.
Chen J, Zhao S, Nakada K, Kuge Y, Tamaki N, Okada F, Wang J, Shindo M, Higashino F, Takeda K, Asaka M, Katoh H, Sugiyama T, Hosokawa M, Kobayashi M
The American Journal of Pathology 162 ( 4 ) 1283 - 1291 2003.4
-
Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V.
Mochizuki T, Kuge Y, Zhao S, Tsukamoto E, Hosokawa M, Strauss HW, Blankenberg FG, Tait JF, Tamaki N
Journal of Nuclear Medicine 44 ( 1 ) 92 - 97 2003.1
-
Fluorodeoxyglucose uptake and glucose transporter expression in experimental inflammatory lesions and malignant tumours: effects of insulin and glucose loading. Nucl Med Commun
Zhao S, Kuge Y, Tsukamoto E, Mochizuki T, Kato T, Hikosaka K, Nakada K, Hosokawa M, Kohanawa M, Tamaki N.
Nucl Med Commun 23 ( 6 ) 545 - 550 2002.6
-
FDG uptake and glucose transporter subtype expression in experimental tumor and inflammation models.
Mochizuki T, Tsukamoto E, Kuge Y, Kanegae K, Zhao S, Hikosaka K, Hosokawa M, Kohanawa M, Tamaki N.
J Nucl Med 42 ( 10 ) 1551 - 1555 2001.10
-
Effects of insulin and glucose loading on FDG uptake in experimental malignant tumours and inflammatory lesions.
Zhao S, Kuge Y, Tsukamoto E, Mochizuki T, Kato T, Hikosaka K, Hosokawa M, Kohanawa M, Tamaki N.
Eur J Nucl Med 28 ( 6 ) 730 - 735 2001.6
-
Avidin chase can raduce myelotoxicity associated with radioimmunotherapy of experimental liver micrometastases in mice.
Sato N, Saga T, Sakahara H, Nakamoto Y, Zhao S, Kuroki M, Endo K, Konishi J.
Jpn J Cancer Res 91 ( 6 ) 622 - 628 2000.6
-
Radioimmunotherapy of human glioma xenografts in nude mice by indium-111 labelled internalising monoclonal antibody.
Saga T, Sakahar H, Nakamoto Y, Sato N, Zhao S, Aoki T, Miyatake S, Namba Y, Konishi J.
Eur J Cancer 35 ( 8 ) 1281 - 1285 1999.8
-
Radioimmunotherapy for liver micometastases in mice: pharmacokinetics, dose estimation, and long-term effect.
Saga T, Sakahara H, Nakamoto Y, Sato N, Zhao S, Iido Y, Kuroki M, Endo K, Konishi J.
Jpn J Cancer Res 90 ( 3 ) 342 - 348 1999.3
-
A novel immunoscintigraphy technique using metabolizable linker with angiotensin II treatment.
Nakamoto Y, Sakahar H, Saga T, Sato N, Zhao S, Arano Y, Fujioka Y, Saji H, Konishi J.
Br J Cancer 79 ( 11/12 ) 1794 - 1799 1999.4